Fulcrum Therapeutics, Inc. (FULC)
14.33
-0.27
(-1.85%)
USD |
NASDAQ |
Dec 10, 12:40
Fulcrum Therapeutics Total Assets (Quarterly): 214.86M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 1.386B |
| Biogen, Inc. | 29.21B |
| CorMedix, Inc. | 750.86M |
| Apellis Pharmaceuticals, Inc. | 1.059B |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.49M |
| Shareholders Equity (Quarterly) | 198.37M |
| Debt to Equity Ratio | 0.0353 |
| Current Ratio | 17.70 |
| Net Debt Paydown Yield | 0.11% |